As the trusted source of premier market intelligence, IMS stands as a formidable force that many companies rely on for guidance through the unpredictable Greek pharmaceutical landscape. General Manager Nikolaos Kostaras proudly speaks about spearheading the affiliate through many transformative changes, defining its core proficiencies and looking to the future of the newly-formed Quintiles-IMS organization.
The merger of Quintiles and IMS was made definitive in May 2016; having been with IMS for over seven years, how has this global corporate change affected the Greek affiliate?
"Apart from our strong, robust data an analytical skills, IMS Legacy’s core capabilities are anchored on being able to consult on reliable go-to-market strategies."
